KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 248 filers reported holding KARUNA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,195,128 | -18.0% | 7,068 | +5.1% | 0.01% | -9.1% |
| Q2 2023 | $1,457,882 | +16.1% | 6,723 | -2.7% | 0.01% | 0.0% |
| Q1 2023 | $1,255,314 | -42.4% | 6,911 | -37.7% | 0.01% | -42.1% |
| Q4 2022 | $2,180,561 | +7.0% | 11,097 | +22.5% | 0.02% | 0.0% |
| Q3 2022 | $2,038,000 | +69.7% | 9,062 | -4.6% | 0.02% | +111.1% |
| Q2 2022 | $1,201,000 | -5.9% | 9,495 | -5.7% | 0.01% | +12.5% |
| Q1 2022 | $1,276,000 | +2.3% | 10,070 | +5.8% | 0.01% | +14.3% |
| Q4 2021 | $1,247,000 | +11.9% | 9,521 | +4.5% | 0.01% | 0.0% |
| Q3 2021 | $1,114,000 | +4.8% | 9,109 | -2.3% | 0.01% | +16.7% |
| Q2 2021 | $1,063,000 | -0.6% | 9,321 | +4.8% | 0.01% | -14.3% |
| Q1 2021 | $1,069,000 | +126.0% | 8,895 | +91.2% | 0.01% | +133.3% |
| Q4 2020 | $473,000 | – | 4,653 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
| Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
| Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
| First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
| Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
| DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
| Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
| GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
| MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
| Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |